Jim Simons
TLSI icon

Jim Simons’s TriSalus Life Sciences TLSI Stock Holding History

Jim Simons’s Portfolio TLSI Stock Details TLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$124K Buy
+30,900
New +$151K ﹤0.01% 2999
2025
Q2 		– Sell
-20,200
Closed -$112K – 3900
2025
Q1 		$112K Buy
20,200
+6,800
+51% +$36.2K ﹤0.01% 3179
2024
Q4 		$67.1K Buy
+13,400
New +$56.6K ﹤0.01% 3345

Other funds holding TLSI

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.57B AUM 9.46% 1-Year Est. Return

Jim Simons's TLSI Position: Q1 2026 in Review

Jim Simons opened a new position in TriSalus Life Sciences (TLSI) in Q1 2026: 30,900 shares worth $124K. The stake represents ﹤0.01% of the portfolio and ranks #2999 among its holdings. This is a return to the name: Jim Simons previously reported a position in TLSI as recently as Q1 2025.

Jim Simons first reported a position in TLSI in Q4 2024 and has held it in 3 quarters since. 84 funds tracked by Wall St. Rank hold TLSI as of Q1 2026.

  • Jim Simons held 30,900 shares of TriSalus Life Sciences worth $124K as of Q1 2026.
  • TriSalus Life Sciences was a new Jim Simons position in Q1 2026.
  • TriSalus Life Sciences made up ﹤0.01% of Jim Simons's portfolio in Q1 2026, its #2999 holding.
  • Jim Simons first reported a position in TriSalus Life Sciences in Q4 2024 and has held it in 3 quarters since.
  • 84 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.